Ascendia Solidifies Leading CDMO Position By Ranking on Inc. 5000 List AgainOct 12, 2021, 12:00:00 AM
Considerations in Development and Manufacturing of Complex Injectables for Early Phase StudiesAug 3, 2021, 12:00:00 AM